Advertisement
Observational findings over 5+ years of follow-up argue for caution in this population
Our experts recap the most notable changes and developments
Novel TAVR deployment technique improves outcomes without compromising safety
Database analysis sets stage for a multicenter trial assessing TAVR’s potential role
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Nationwide database study finds racial and regional variations
Findings offer reassurance, clarify understanding of cardiorenal syndrome
Cohort study provides insights on TAVR in an understudied group
Study focuses on time interval between LV and aortic systolic pressure peaks
PARTNER 3 and CoreValve Low Risk reveal pros and cons of both approaches
Pathophysiologic understanding and deep experience with BAV are invaluable
Advertisement
Advertisement